Clinical Trials Browser

Phase 1/2 × Neoplasm Metastasis × abiraterone × Clear all

NCT06863272 2026-03-16

IDeate-Prostate02

Phase 1/2 Recruiting

Neoplasm Metastasis, Prostatic Neoplasms, Castration-Resistant